Aquestive Therapeutics, Inc. AQST
3.56 USD +0.04 (+0.99%)
Nov 11, 2026, 9:33 AM EST
3.56 Day range 3.58
2.93 52-week range 6.74
- YTD
- -44.97%
- 1 year
- -37.52%
News
globenewswire.com Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference WARREN, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a biopharmaceutical company advancing medicines to bring meaningful…
globenewswire.com Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting WARREN, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a biopharmaceutical company advancing medicines to bring meaningful…
defenseworld.net Traders Purchase Large Volume of Put Options on Aquestive Therapeutics (NASDAQ:AQST) Aquestive Therapeutics, Inc. (NASDAQ: AQST - Get Free Report) was the target of unusually large options trading activity on Tuesday. Stock traders purchased 6,009 put options on the company. This is…
seekingalpha.com Aquestive Therapeutics, Inc. (AQST) Q3 2026 Earnings Call Transcript Aquestive Therapeutics, Inc. ( AQST ) Q3 2026 Earnings Call November 4, 2026 8:00 AM EST Company Participants Faith Pomeroy-Ward Daniel Barber - CEO, President & Director Ernie Toth - Senior VP & CFO…
marketbeat.com What Aquestive Therapeutics (AQST) Said on Its Q3 Earnings Call Aquestive Therapeutics NASDAQ: AQST said it resubmitted its application for Anaphylm, an epinephrine sublingual film intended for severe allergic reactions, before the end of the third quarter and is…
benzinga.com Aquestive Therapeutics Q3 2026 Earnings Call Transcript Aquestive Therapeutics (NASDAQ:AQST) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…
benzinga.com Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $51.040M Est Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $51.040 million estimate.
benzinga.com Aquestive Therapeutics Q3 EPS $(0.13) Misses $(0.11) Estimate, Sales $7.557M Miss $11.017M Estimate Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 7.14 percent increase over…
benzinga.com FDA Accepts Aquestive Therapeutics’ Anaphylm NDA Resubmission; PDUFA Goal Action Date Set For March 16, 2027 FDA accepted the resubmission as complete and classified it as a Class 2 responsePrescription Drug User Fee Act (PDUFA) goal action date set for March 16, 2027Ex-U.S. strategy remains on track with…
benzinga.com Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug Eton Pharmaceuticals licenses Aquestive’s LIBERVANT buccal film for U.S. seizure cluster treatment, with launch set for April 2027.- benzinga.com Eton Pharmaceuticals And Aquestive Therapeutics Enter Exclusive U.S. License And Supply Agreement For LIBERVANT Buccal Film For Seizure Clusters In Patients With Epilepsy; Sees Commercial Availability In April 2027 Differentiated, portable buccal film would offer patients and caregivers an alternative to existing nasal and rectal seizure rescue treatments, a market opportunity that exceeds $450 million annually…
benzinga.com Aquestive Therapeutics Resubmits FDA Application for Pocket-Sized Allergy Treatment Aquestive Therapeutics has resubmitted its New Drug Application to the FDA for Anaphylm, a sublingual film for severe allergic reactions.- benzinga.com HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $10 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains $10 price target.
benzinga.com Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $50.584M Est Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $50.584 million estimate.
benzinga.com Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study Aquestive Therapeutics reports positive study results for Anaphylm sublingual film, paving the way for a Q3 FDA resubmission.
benzinga.com Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Higher On Monday BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained 16.4%, AQST gained 15.4%, STDN rose 13.7%.
benzinga.com Staar Surgical Posts Upbeat Q1 Results, Joins Cisco, Yeti Holdings And Other Big Stocks Moving Higher On Thursday U.S. stocks rose, with Dow Jones up 300 points. STAA shares surged after better-than-expected results. Other big gainers include POET, STUB, MSC, ARX, CSCO, PCT, WOLF, CPA, ONDS, KLAR, and RDW.
benzinga.com Aquestive Therapeutics Q1 2026 Earnings Call: Complete Transcript 
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session 
benzinga.com Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $48.072M Est Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $48.072 million estimate.
benzinga.com Aquestive Therapeutics Q1 EPS $(0.07) Beats $(0.15) Estimate, Sales $14.446M Beat $10.896M Estimate Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 70.83 percent increase over losses…
benzinga.com Earnings Scheduled For May 13, 2026 - benzinga.com Earnings Scheduled For March 4, 2026
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Peakstone Realty Trust, Aquestive Therapeutics, Opera And Other Big Stocks Moving Higher On Monday 
benzinga.com 10 Health Care Stocks Whale Activity In Today's Session 
benzinga.com Benzinga Bulls And Bears: Chevron, Palantir, Aquestive — And Real Estate Stocks Plummet Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
benzinga.com Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Dow Edges Higher; US Economy Adds 50,000 Jobs In December - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday's session after the FDA…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday 
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session 
benzinga.com Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 10 Health Care Stocks Whale Activity In Today's Session
- benzinga.com Earnings Scheduled For August 11, 2025
- benzinga.com Earnings Scheduled For May 12, 2025
- benzinga.com Earnings Scheduled For March 5, 2025
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session - benzinga.com Dow Surges 350 Points; Fed Holds Rates Steady U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also…
- benzinga.com Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession…
- benzinga.com Crude Oil Dips 2%; Signet Jewelers Shares Spike Higher U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&P…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.</
benzinga.com Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.- benzinga.com Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.